Board Meetings

BSE Code Company Date Purpose
table-arrow 500086 Exide Inds. 04-May-2026 Exide Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2026 inter alia to consider and approve the audited financial results of the Company for the financial year ending 31st March 2026 along with the recommendation of final dividend if any on the equity shares for FY 2025-26.
table-arrow 500103 B H E L 04-May-2026 Audited Results Bharat Heavy Electricals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2026 ,inter alia, to consider and approve Further to our communication dated 27th April, 2026, it is informed that, pursuant to Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the Board Meeting to be held on Monday, 4th May, 2026, will also consider recommendation of Final Dividend, if any, for FY 2025-26.
table-arrow 500314 Oriental Hotels 04-May-2026 Oriental Hotels Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday May 04 2026.
table-arrow 500425 Ambuja Cements 04-May-2026 Ambuja Cements Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31 2026 and to consider and recommend dividend if any on the equity shares of the Company for the Financial Year 2025-26.
table-arrow 500770 Tata Chemicals 04-May-2026 Tata Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2026 inter alia to consider and approve i. Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31 2026; and ii. Recommendation of dividend if any for the year ended March 31 2026 for the approval of the shareholders at the ensuing 87th Annual General Meeting of the Company.